These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7721047)

  • 21. Vascular effects and metabolism of angiotensins and their metabolites in the isolated perfused rat kidney.
    Misumi J; Gonzales MF; Ogihara T; Corvol P; Ménard J
    Clin Exp Hypertens A; 1983; 5(7-8):1151-62. PubMed ID: 6357560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine-angiotensin II interactions. Part I. Role of adenosine in regulating angiotensin II-induced potentiation of noradrenergic neurotransmission and angiotensin II-induced vasoconstriction.
    Holycross BJ; Jackson EK
    J Pharmacol Exp Ther; 1989 Aug; 250(2):433-41. PubMed ID: 2547930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual action of angiotensin II on coronary resistance in the isolated perfused rabbit heart.
    Pörsti I; Hecker M; Bassenge E; Busse R
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):650-8. PubMed ID: 7510856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radial artery has higher receptor-mediated contractility but similar endothelial function compared with mammary artery.
    He GW; Yang CQ
    Ann Thorac Surg; 1997 May; 63(5):1346-52. PubMed ID: 9146326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations of cyclo-oxygenase products and NO in responses to angiotensin II of resistance arteries from the spontaneously hypertensive rat.
    Côrtes SF; Andriantsitohaina R; Stoclet JC
    Br J Pharmacol; 1996 Dec; 119(8):1635-41. PubMed ID: 8982512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of angiotensin I and II and their interactions with some prostanoids in perfused human umbilical arteries.
    Bjøro K
    Prostaglandins; 1985 Dec; 30(6):989-98. PubMed ID: 3911295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation by the endothelium of sympathetic vasoconstriction in an in vitro preparation of the rat tail artery.
    Thorin E; Atkinson J
    Br J Pharmacol; 1994 Jan; 111(1):351-7. PubMed ID: 8012718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptidases and smooth muscle cell angiotensin II receptor pharmacology.
    Cohen RB; Webb ML; Dickinson KE
    Peptides; 1993; 14(2):345-52. PubMed ID: 8483812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic GMP modulators on vascular adrenergic neurotransmission.
    Tesfamariam B; Weisbrod RM; Cohen RA
    J Vasc Res; 1992; 29(5):396-404. PubMed ID: 1358232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin I conversion by the microcirculation of the nonhuman primate.
    Cornish KG; Gilmore JP
    Blood Vessels; 1981; 18(3):128-33. PubMed ID: 6261858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of renin release and intrarenal formation of angiotensin. Studies in the isolated perfused rat kidney.
    Hofbauer KG; Zschiedrich H; Gross F
    Clin Exp Pharmacol Physiol; 1976; 3(1):73-93. PubMed ID: 985607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Captopril attenuates adrenergic vasoconstriction in rat mesenteric arteries by angiotensin-dependent and -independent mechanisms.
    Collis MG; Keddie JR
    Clin Sci (Lond); 1981 Sep; 61(3):281-6. PubMed ID: 7021045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-(1-7) is involved in the endothelium-dependent modulation of phenylephrine-induced contraction in the aorta of mRen-2 transgenic rats.
    Lemos VS; Côrtes SF; Silva DM; Campagnole-Santos MJ; Santos RA
    Br J Pharmacol; 2002 Apr; 135(7):1743-8. PubMed ID: 11934815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure.
    Farquharson CA; Struthers AD
    J Am Coll Cardiol; 2002 Mar; 39(5):767-75. PubMed ID: 11869839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of endothelial cell function for angiotensin conversion in serial-arranged arterioles.
    Tang T; Connelly BA; Joyner WL
    J Vasc Res; 1995; 32(2):129-37. PubMed ID: 7734659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Responses of femoral resistance vessels to angiotensin in vitro.
    Juul B; Aalkjaer C; Mulvany MJ
    Eur J Pharmacol; 1987 Mar; 135(1):61-8. PubMed ID: 3552708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II dilates bovine adrenal cortical arterioles: role of endothelial nitric oxide.
    Gauthier KM; Zhang DX; Edwards EM; Holmes B; Campbell WB
    Endocrinology; 2005 Aug; 146(8):3319-24. PubMed ID: 15890772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The vascular-disrupting agent, combretastatin-A4-phosphate, enhances neurogenic vasoconstriction in rat small arteries.
    Su J; Laursen BE; Eskildsen-Helmond Y; Horsman MR; Simonsen U
    Eur J Pharmacol; 2012 Nov; 695(1-3):104-11. PubMed ID: 22981665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation by angiotensins I and II of ACTH release from goldfish pituitary cell columns.
    Weld MM; Fryer JN
    Gen Comp Endocrinol; 1987 Oct; 68(1):19-27. PubMed ID: 2822525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion of angiotensin I to angiotensin II and inactivation of bradykinin in canine peripheral vascular beds.
    Suzuki M; Ohyama Y; Satoh S
    J Cardiovasc Pharmacol; 1984; 6(2):244-50. PubMed ID: 6200711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.